ATE250935T1 - Neuartige cytokine - Google Patents

Neuartige cytokine

Info

Publication number
ATE250935T1
ATE250935T1 AT91919165T AT91919165T ATE250935T1 AT E250935 T1 ATE250935 T1 AT E250935T1 AT 91919165 T AT91919165 T AT 91919165T AT 91919165 T AT91919165 T AT 91919165T AT E250935 T1 ATE250935 T1 AT E250935T1
Authority
AT
Austria
Prior art keywords
protein
activity
adipocyte formation
result
cells
Prior art date
Application number
AT91919165T
Other languages
English (en)
Inventor
Ichiro C O Sankyo Co Kawashima
Jun C O Sankyo Company Ohsumi
Kenji C O Sankyo Compa Miyadai
Yo C O Sankyo Compan Takiguchi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26343378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE250935(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE250935T1 publication Critical patent/ATE250935T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5431—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91919165T 1990-11-08 1991-11-07 Neuartige cytokine ATE250935T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30355890 1990-11-08
JP878591 1991-01-29
PCT/JP1991/001526 WO1992008735A1 (en) 1990-11-08 1991-11-07 Novel cytokine

Publications (1)

Publication Number Publication Date
ATE250935T1 true ATE250935T1 (de) 2003-10-15

Family

ID=26343378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919165T ATE250935T1 (de) 1990-11-08 1991-11-07 Neuartige cytokine

Country Status (11)

Country Link
EP (1) EP0556395B1 (de)
JP (1) JP2752819B2 (de)
KR (1) KR0139095B1 (de)
AT (1) ATE250935T1 (de)
CA (1) CA2095840A1 (de)
DE (1) DE69133321T2 (de)
DK (1) DK0556395T3 (de)
ES (1) ES2206440T3 (de)
HK (1) HK1017817A1 (de)
HU (1) HU217803B (de)
WO (1) WO1992008735A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0566410A3 (en) 1992-04-17 1994-08-24 Sankyo Co Derivatives of adipogenesis inhibitory factor, their preparation and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11

Also Published As

Publication number Publication date
EP0556395B1 (de) 2003-10-01
CA2095840A1 (en) 1992-05-09
WO1992008735A1 (en) 1992-05-29
EP0556395A4 (en) 1994-08-24
ES2206440T3 (es) 2004-05-16
HK1017817A1 (en) 1999-11-26
HU9301330D0 (en) 1993-09-28
DE69133321T2 (de) 2004-07-29
EP0556395A1 (de) 1993-08-25
DE69133321D1 (de) 2003-11-06
KR930702525A (ko) 1993-09-09
HUT66624A (en) 1994-12-28
KR0139095B1 (ko) 1998-04-30
DK0556395T3 (da) 2004-02-02
JPH0592997A (ja) 1993-04-16
HU217803B (hu) 2000-04-28
JP2752819B2 (ja) 1998-05-18

Similar Documents

Publication Publication Date Title
ES8802182A1 (es) Un procedimiento para preparar una linfotoxina.
YU71395A (sh) Acilovani analozi insulina
DK0559884T3 (da) Rekombinante virusvektorer til ekspression i muskelceller
DE69018920T2 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
ATE323510T1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE404668T1 (de) Wachstumsfaktor-homologe zvegf-3
DK0464105T3 (da) Melaninkoncentrerende hormoner og DNA til ekspression af samme
NO165804C (no) Veksthormon-frigjoerende peptider og anvendelse derav.
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
KR920004571A (ko) 헤파린 결합 향신경성 인자(hbnf)를 암호하는 유전자, 이를 포함하는 발현 벡터 및 숙주 세포, 및 hbnf의 생성 방법 및 사용방법
JPS6420095A (en) Polypeptide having anti-blood coagulating action
DE68917837D1 (de) Peptid-Verbindungen.
NZ336555A (en) A recombinant molecule containing the DefH9 promoter combined with a DNA sequence useful for producing parthenocarpic transgenic plants and enhancing fruit setting and development
ATE154362T1 (de) Verfahren zur herstellung von pai-2
DE69133321D1 (de) Neuartige cytokine
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
MXPA01011158A (es) Factor de crecimiento homologo zvegf4.
Catalano-Sherman et al. Amino acid sequence of a major human amelogenin protein employing Edman degradation and cDNA sequencing
Suzuki et al. Sea urchin protease specific to the SPKK motif in histone
Gibson et al. Human and sheep growth-plate cartilage type X collagen synthesis and the influence of tissue storage
Perez-Polo et al. The Physical and Biological Properties of 7S and β-NGF from the Mouse Submaxillary Gland
RU93033086A (ru) Белки, днк, способ получения белка, вектор, хозяйская клетка, фармацевтические композиции, способы лечения и профилактики
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.
ATE360078T1 (de) Mannanase aus kaffee
EA199900339A1 (ru) Ген роста человека и область гена, ответственная за низкий рост

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0556395

Country of ref document: EP

RZN Patent revoked